Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs
Hypersensitivity, Immediate
0301 basic medicine
Ovalbumin
Prostaglandin D2
Blotting, Western
Guinea Pigs
Urinary Bladder
6-Ketoprostaglandin F1 alpha
Dinoprost
Dinoprostone
Isoenzymes
Linoleic Acid
Trachea
03 medical and health sciences
Cyclooxygenase 2
Prostaglandin-Endoperoxide Synthases
Animals
Eicosanoids
Female
Bronchial Hyperreactivity
Food Science
DOI:
10.1152/ajpregu.00075.2001
Publication Date:
2015-03-03T20:24:04Z
AUTHORS (6)
ABSTRACT
This study investigated the capacity of conjugated linoleic acids (CLA) to reduce ex vivo antigen-induced release of eicosanoids in a type I hypersensitivity model. Guinea pigs were fed a diet containing 0.25% safflower oil (control) or 0.25% CLA [43% trans( t)10, cis ( c)12; 41% c9, t11/ t9, c11 18:2] for 2 wk before and during sensitization to ovalbumin (OVA). Lungs, tracheas, and bladders were incubated in physiological saline solution (PSS) for 1 h (basal mediator release) and challenged with OVA (0.01 g/l PSS) for 1 h (mediator release in response to antigen). Eicosanoids were quantified by HPLC/tandem mass spectrometry or enzyme immunoassay. CLA feeding resulted in no change in basal release but decreased eicosanoid release from sensitized tissues in response to antigen challenge in the following manner: thromboxane B2, 6-keto-prostaglandin (PG)F1α, PGF2α, PGD2, PGE2by 57–75% in lung, 45–65% in trachea, and 38–60% in bladder; and leukotriene C4/D4/E4by 87, 90, and 50% in lung, trachea, and bladder, respectively. These data indicate that feeding CLA reduces lipid-derived inflammatory mediators produced by this type I hypersensitivity model.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (60)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....